中集車輛(1839.HK)高開4.9% 創業板IPO獲註冊批文 A+H上市在即
格隆匯5月20日丨中集車輛(1839.HK)高開4.9%,報6.42港元,最新市值113億港元。昨日,證監會公吿同意中集車輛創業板IPO註冊。中集車輛是全球半掛車和專用車高端製造領導者,主要產品包括半掛車、專用車上裝以及冷藏廂式車廂體。本次中集車輛創業板擬發行股份不超過3.1億股,招股書披露擬募資金額約20億元。2020年中集車輛全年營業收入達265.0億元,同比增長13.3%,創歷史新高。2019年7月,中集車輛率先在香港聯交所上市,本次獲准註冊後,中集車輛將正式成為“A+H”的全球半掛車和專用車高端製造第一股。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.